Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Adult Patients
.
Show all posts
Showing posts with label
Adult Patients
.
Show all posts
Monday, September 30, 2024
FDA Approves Rytelo (imetelstat) for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
›
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer...
Friday, March 1, 2024
FDA Approves Jaypirca (pirtobrutinib) for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma
›
Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), announced the U.S. Food and Drug Administration (FDA) approved Jaypirc...
Thursday, March 10, 2022
FDA Approves Recorlev (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome
›
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), announce the U.S. Food and Drug Administration (FDA) approval of Recorlev ® (levoketoconazo...
Monday, February 17, 2020
FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients
›
In continuation of my update on lemborexant Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) today announced that...
›
Home
View web version
